Brief: Chromadex Corp Reports First Quarter 2023 Financial Results

Niagen Bioscience

10/05/2023 21:25

May 10 (Reuters) - Chromadex Corp  CDXC.O :
    * CHROMADEX CORPORATION REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
    * CHROMADEX CORP Q1 SALES $22.6 MILLION
    * CHROMADEX CORP Q1 LOSS PER SHARE $0.03
    * CHROMADEX CORP - QTRLY NET LOSS WAS $1.9 MILLION, OR $0.03
LOSS
PER SHARE
    * CHROMADEX CORP - FOR FULL YEAR, COMPANY EXPECTS AT LEAST
12.5%
REVENUE GROWTH YEAR-OVER-YEAR

Source text for Eikon:  ID:nBw7HDW2ya 
Further company coverage:  CDXC.O 

 ((Reuters.Briefs@thomsonreuters.com;))